Research led by Prof. Ryan Jensen at Yale Medical School focuses on elucidating the links between BRCA2 gene mutations and breast cancer. Learn how researchers in his lab use Bio-Rad's V3 Western Workflow to study interactions between BRCA2 proteins and the DNA repair protein RAD51. Understanding how these proteins interact in carcinogenesis and tumor growth will provide a better understanding of breast cancer mechanisms that could lead to new therapies. For more information, visit http://www.biorad.com/yt/7/V3.
Drug DiscoveryInformaticsMicrofluidicsMolecular Biology